Condition: Heart Failure · Sponsor: Impulse Dynamics
The primary objective of this study is to evaluate the impact of Cardiac Contractility Modulation (CCM) therapy on the initiation and up-titration of Guideline-Directed Medical Therapy (GDMT) in patients with heart failure (HF). This will be assessed by the change in Quad Medication Score (QMS) from baseline (pre-CCM) to 6-month following post-CCM device implant.
This description comes directly from the study's public registry record.
Gary Cranke · (856) 642-9933 · gcranke@impulsedynamics.com
Rachael Riccitello · (856) 642-9933 · rriccitello@impulsedynamics.com
Always discuss trial participation with your own doctor first.
| Gemelli University Hospital | Rome, Italy, Italy | Recruiting |
| AO dei Colli - O.Monaldi | Naples, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06580392